logo
menu
← Return to the newsfeed...

FuturaGene starts final Brazilian field trial for yield enhanced eucalyptus plantations

FuturaGene has received approval from the Brazilian National Technical Commission on Biosafety (CTNBio) to initiate its fourth regulatory field trial for yield enhanced eucalyptus plantations in Brazil. The company specializes in the enhancement of yield and sustainability of woody crops for plantation forestry, biopower and biofuel markets.

The trial is designed to evaluate plantation agronomic properties and biosafety of a specific genetically modified event.

Biosafety data in Brazil are required to obtain market approval for modified organisms in Brazil. FuturaGene has planted three additional regulatory trials over the last eight months. The last trial is planned to commence within the next two weeks, with the initiation of this trial denoting an important milestone in the regulatory process for FuturaGene. The planting of the trial will be the culmination of a series of regulated selection, evaluation and biosafety trials which were initiated back in 2006.

'Over the past six years we have successfully demonstrated that our technology delivers sustainably increased yields for plantation forestry. This pioneering fourth trial is a key step towards the commercial deployment of our first plantation product designed to meet the ever increasing demands for energy at a time of declining land and water resources,' says Dr Stanley Hirsch, CEO of FuturaGene.

If the regulatory trials are completed successfully, FuturaGene plans to submit a dossier to the CTNBio requesting regulatory approval to deploy its yield enhanced eucalyptus.





204 queries in 0.789 seconds.